IL111501A0 - Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis - Google Patents

Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis

Info

Publication number
IL111501A0
IL111501A0 IL11150194A IL11150194A IL111501A0 IL 111501 A0 IL111501 A0 IL 111501A0 IL 11150194 A IL11150194 A IL 11150194A IL 11150194 A IL11150194 A IL 11150194A IL 111501 A0 IL111501 A0 IL 111501A0
Authority
IL
Israel
Prior art keywords
plasminogen
lys
treatment
pharmaceutical compositions
coronary thrombosis
Prior art date
Application number
IL11150194A
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL111501A0 publication Critical patent/IL111501A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11150194A 1993-11-05 1994-11-02 Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis IL111501A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK931256A DK125693D0 (en) 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
IL111501A0 true IL111501A0 (en) 1995-01-24

Family

ID=8102801

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11150194A IL111501A0 (en) 1993-11-05 1994-11-02 Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis

Country Status (5)

Country Link
AU (1) AU8058194A (en)
DK (1) DK125693D0 (en)
IL (1) IL111501A0 (en)
WO (1) WO1995012407A1 (en)
ZA (1) ZA948721B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
CN106890320A (en) * 2015-12-18 2017-06-27 深圳瑞健生命科学研究院有限公司 It is a kind of for preventing or treating acute and Chronic Thrombotic method
ES2961967T3 (en) 2015-12-18 2024-03-14 Talengen Int Ltd Plasminogen for use in the treatment of diabetic angiocardiopathy
CN108472342B (en) 2015-12-18 2022-11-15 泰伦基国际有限公司 A method for preventing or treating acute and chronic thrombosis
WO2018107705A1 (en) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 Method for promoting insulin secretion
WO2018107686A1 (en) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 Method for treating atherosclerosis and complications thereof
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
JP7168990B2 (en) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド Methods and drugs for preventing and treating obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE

Also Published As

Publication number Publication date
DK125693D0 (en) 1993-11-05
AU8058194A (en) 1995-05-23
WO1995012407A1 (en) 1995-05-11
ZA948721B (en) 1995-05-08

Similar Documents

Publication Publication Date Title
AU1515295A (en) Inhibitors of urokinase plasminogen activator
ZA933023B (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds.
HUP9802093A3 (en) Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis
IL111501A0 (en) Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis
EP0692968A4 (en) Urokinase plasminogen activator fragments
EP0682700A4 (en) Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis.
NZ219829A (en) Tissue-type plasminogen activator modified in the region of amino acids 67-69 and pharmaceutical compositions thereof
AU590840B2 (en) Methods for purification of single-chain and double-chain tissue plasminogen activator
AU7431796A (en) Brain-associated inhibitor of tissue-type plasminogen activator
HU912739D0 (en) Stabilization of glycozylized tissue plasminogene activator (t-pa)
IL91774A0 (en) Preparation of plasminogen activator expressed in prokaryotes
EP0750511A4 (en) Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
AU2974300A (en) Plasminogen kringle 4 region fragments and methods of use
EP1030679A4 (en) Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
AU612562B2 (en) A composition comprising a plasmin inhibitor and a plasminogen activator for the treatment of thrombosis
EP0337817A3 (en) Plasminogen activator and thrombolytic agent
IL78450A0 (en) Agent containing tissue plasminogen activator(t-pa)
AU609337B2 (en) Tissue plasminogen activator (t-pa) muteins and processes for the preparation thereof
IE882534L (en) Peg complex of tissue plasminogen activator
IE901349L (en) Plasminogen activator complex of pro-urokinase and serum¹albumin
GB8901422D0 (en) New tissue plasminogen activator
IE872091L (en) Combination of tissue plasminogen activator and a¹prostaglandin
GB9311831D0 (en) Pharmaceutical compositions comprising plasminogen activators
AU619697C (en) Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
GB9000629D0 (en) Tissue plasminogen activator